Atreca, Inc. Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Atreca, Inc. is a biotechnology company based in South San Francisco focused on developing novel cancer immunotherapies by decoding the human immune response. The firm emphasizes a research-driven approach aimed at understanding how immune activity in cancer patients can influence treatment outcomes. Its work relies on a proprietary platform to profile the immune repertoire and guide therapeutic discovery. Founded by scientists, industry experts, and investors, Atreca operates within the biopharma research ecosystem as a partner for advancing immunotherapy programs. As a relatively small biotechnology research company, it concentrates on translating immune insights into therapeutics with potential clinical impact. In January 2023, Atreca appointed a new chief medical officer.